MARATTO

review · Fungal Genetics and Biology

Update on the structure and function of Candida albicans drug efflux protein, Cdr1

20246 citationsOpen accessUniversity of the Free State

Abstract

Candida albicans is an important human pathogenic yeast, that can become resistant to commonly used antifungal agents, such as azoles. One mechanism of drug resistance is efflux via ATP binding cassette transporters, such as Cdr1. Several studies have investigated the structural organization, binding mechanisms, function and regulation of Cdr1. This review summarizes the findings on the structure and function of Cdr1 and highlights important aspects to consider in future research relating to multidrug ABC transporters.

Research topics

  • Pneumocystis jirovecii pneumonia detection and treatment
  • Antibiotic Resistance in Bacteria
  • Antifungal resistance and susceptibility

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.fgb.2024.103938

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.